Meeting
2015 Genitourinary Cancers Symposium
A genomic classifier to improve prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Authors
Eric A. Klein
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH
Eric A. Klein , Kasra Yousefi , Zaid Haddad , Voleak Choeurng , Christine Buerki , Andrew J. Stephenson , Jianbo Li , Michael W. Kattan , Cristina Magi-Galluzzi , Elai Davicioni
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 154)
DOI
10.1200/jco.2015.33.7_suppl.154
Abstract #
154
Poster Bd #
G16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Planned interim analysis of perioperative safety of fluzoparib combined with abiraterone in the neoadjuvant treatment of locoregional high-risk prostate cancer: Results from multicenter, phase 2 FAST-PC trial.
First Author: Yao Zhu
Poster
2016 Genitourinary Cancers Symposium
Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk.
First Author: Robert Den
Poster
2014 Genitourinary Cancers Symposium
Independent validation of a genomic classifier in an at-risk population of men conservatively managed after radical prostatectomy.
First Author: Eric A. Klein
Poster
2014 Genitourinary Cancers Symposium
Validation of a genomic classifier for predicting biochemical failure following postoperative radiation therapy in high-risk prostate cancer.
First Author: Robert Benjamin Den